Metabolite Profile of Glutamate Receptor Subtype 1 (mGluR1) in Cerebrospinal Fluid (CSF)
This test measures levels of metabolites associated with the glutamate receptor subtype 1 (mGluR1) in cerebrospinal fluid, which may help evaluate neurological function or potential metabolic pathways.
["This test assesses biochemical markers linked to brain chemistry, potentially useful in neurological evaluations."]
Key facts at a glance
- LOINC
- 94361-3
- Short code
- mGluR1 IgG CSF Ql IF
- Synonyms
- mGluR1 IgG CSF Ql IF
- Category
- coagulation
- Sample
- csf
- Container
- Sterile tube
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- if
- CPT
- 82784
- Specimen volume
- 1-2 mL
- Stability
- Immediate analysis required, Refrigerated: 1h
- Hemolysis max
- 200
- TAT
- 4–24 hours
- Order
- routine
Why This Test Might Be Ordered
Your healthcare provider may recommend this test if you have symptoms or conditions related to neurological function, such as seizures, movement disorders, or suspected metabolic imbalances in the brain. It could also be part of a broader evaluation for genetic or metabolic disorders affecting receptor pathways.
What to Expect Before the Test
No special preparation is typically required. You may be asked to fast or avoid certain foods/drugs depending on the clinical context. Your provider will guide you on any specific instructions. A sample of cerebrospinal fluid (CSF) will be collected through a lumbar puncture (spinal tap).
What the Test Results Mean
Results may indicate abnormal metabolic activity linked to mGluR1 pathways, which could suggest underlying neurological or metabolic conditions. Interpretation depends on clinical context, including your symptoms and other test results. Your provider will discuss findings with you.
Common Conditions Monitored
This test may be used to monitor conditions affecting glutamate receptor function, such as neurodegenerative diseases, metabolic encephalopathies, or genetic disorders involving neurotransmitter pathways. It is not a routine screening test.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
While mGluR1 metabolites are not commonly measured in routine clinical practice, elevated or altered levels in CSF may indicate specific neurological or metabolic disorders. These findings would require correlation with symptoms, family history, and other diagnostic tests. Further research is needed to clarify clinical utility in broader patient populations.
Short name
mGluR1 Metabolite Screening (CSF)
Frequently asked questions
What is cerebrospinal fluid (CSF)?
How is this test different from blood tests?
Can I get this test if I have a spinal condition?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy